Heart Test Laboratories (NASDAQ:HSCS) Announces Quarterly Earnings Results

Heart Test Laboratories (NASDAQ:HSCS) announced its quarterly earnings results on Monday. The company reported ($2.27) EPS for the quarter, beating the consensus estimate of ($2.30) by $0.03, Zacks reports.

Heart Test Laboratories Price Performance

HSCS stock traded up $0.08 during trading on Monday, hitting $3.85. 25,193 shares of the stock traded hands, compared to its average volume of 131,480. The stock has a market cap of $3.52 million, a price-to-earnings ratio of -0.17 and a beta of 3.23. Heart Test Laboratories has a one year low of $2.36 and a one year high of $18.50. The company has a current ratio of 4.49, a quick ratio of 4.02 and a debt-to-equity ratio of 0.08. The company has a 50 day simple moving average of $3.26 and a 200 day simple moving average of $3.83.

Analyst Ratings Changes

Separately, Ascendiant Capital Markets reiterated a “buy” rating and set a $15.00 price target on shares of Heart Test Laboratories in a report on Monday, September 23rd.

About Heart Test Laboratories

Heart Test Laboratories, Inc, a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals.